Digital Health CEO, Board Member, Advisor, & Investor | Passionate About Value-Based Care | Advocate for Early Detection
In advanced cancer care, the complexity of polypharmacy often leads to serious side effects, adverse drug events, and medication inefficacy. A recent study shows that targeted palliative care, focusing on the most impactful symptoms, can reduce the need for extensive medications and improve patient quality of life. With advanced technology enabling earlier cancer detection, we can further minimize the challenges of polypharmacy and enhance patient outcomes. https://bit.ly/3SCRYy3 #CancerCare #Polypharmacy #HealthcareInnovation #PalliativeCare
